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In sub-Saharan Africa, children below 5 years bear the greatest burden of severe malaria
because they lack naturally acquired immunity that develops following repeated exposure
to infections by Plasmodium falciparum. Antibodies to the surface of P. falciparum
infected erythrocytes (IE) play an important role in this immunity. In children under
the age of 6 months, relative protection from severe malaria is observed and this is
thought to be partly due to trans-placental acquired protective maternal antibodies.
However, the protective effect of maternal antibodies has not been fully established,
especially the role of antibodies to variant surface antigens (VSA) expressed on IE.
Here, we assessed the immune pressure on parasites infecting infants using markers
associated with the acquisition of naturally acquired immunity to surface antigens. We
hypothesized that, if maternal antibodies to VSA imposed a selection pressure on
parasites, then the expression of a relatively conserved subset of var genes called group
A var genes in infants should change with waning maternal antibodies. To test this, we
compared their expression in parasites from children between 0 and 12 months and
above 12 months of age. The transcript quantity and the proportional expression of
group A var subgroup, including those containing domain cassette 13, were positively
associated with age during the first year of life, which contrasts with above 12 months.
This was accompanied by a decline in infected erythrocyte surface antibodies and
an increase in parasitemia during this period. The observed increase in group A var
gene expression with age in the first year of life, when the maternal antibodies are
waning and before acquisition of naturally acquired antibodies with repeated exposure,
is consistent with the idea that maternally acquired antibodies impose a selection
pressure on parasites that infect infants and may play a role in protecting these infants
against severe malaria.
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INTRODUCTION
In many malaria endemic regions, incidence of severe malaria
is rare in children younger than 6 months (1, 2) suggesting
a potential role of maternal antibodies in protection from
malaria. In a cross sectional survey in Benin and Gambia,
it was reported that the mean parasite densities among
infants younger than 1 year was significantly lower than in
children aged between 1 and 9 years (3). Several studies
have explored the role of antibodies in this phenomenon
(4–8). However, because of the difficulty in conclusively
linking antibody carriage to clinical protection, the mechanism
of protection and the targets of the maternal antibodies
remain unclear.
An alternative approach to explore the potential role of
host antibodies, is to explore the parasites that cause infections
in infants and seek parasite markers that will act as a read-
out of in vivo antibody selection on the infecting parasites
populations. The PfEMP1 family of antigens that are expressed
on the surface of parasite infected erythrocytes provide a
potentially useful marker for this purpose. PfEMP1 is a
highly diverse family of multi-domain parasite antigens that
are inserted into the infected erythrocyte surface, encoded by
a family of about 60 var genes in every genome (9, 10).
PfEMP1 mediates the binding of Infected Erythrocytes (IE)
to vascular endothelial cells, allowing the parasite to sequester
in the microvasculature of the organs and avoid clearance
by the spleen (11). Therefore, through sequestration, PfEMP1
supports parasite growth and plays an important role in the
pathogenesis of malaria.
Despite their overall high level of diversity, parasites encode
subsets of PfEMP1 antigens that are relatively conserved. A
subset of PfEMP1 referred to as group A and those containing
commonly occurring domain arrangements called domain
cassettes 8 and 13 (DC8 and DC13) are thought to play a role
in the pathogenesis of malaria (12, 13). In vitro studies have
shown that these subsets of PfEMP1 mediate strong binding
to endothelial cells (14) and to non-infected erythrocytes in a
process referred to as rosetting (15, 16). Therefore, through their
cytoadhesive properties, they have been hypothesized to support
parasite growth, increasing the risk of severe malaria. Further,
these var subsets are more commonly expressed in parasites from
children with low host immunity and those with severe malaria
(17, 18). Although most studies on clinical P. falciparum isolates
have found that host age is negatively correlated with expression
of group A and DC8 var genes (18–20), these studies have not
considered var expression in parasites sampled from children
with malaria below 12 months, possibly due to the extreme rarity
of P. falciparum infection in children in this age group (21). In
the study described here, we aimed to overcome the rarity of
parasites sampled from infants bymaking use of a large collection
of parasite isolates that have been collected over a 16-year period.
We hypothesized that if maternal antibodies are important in the
protection of children from malaria in early life, there will be a
positive association between the expression of group A var genes
in parasites and the age of the children in the first 12 months of
life, as maternal antibodies wane.
MATERIALS AND METHODS
Study Site, Sample Collection, and Ethics
The study was carried out at Kilifi County which is situated on
the Kenyan coast. Parasite isolates and plasma samples collected
between 1994 and 2012, from Plasmodium falciparum positive
pediatric admissions and longitudinal cohort children, were used
for the study. Ethical approval was obtained from the Kenya
Medical Research Institute Scientific and Ethics Review Unit
(KEMRI/SERU) under the protocol; KEMRI/SERU/3149, and
informed consent was obtained from the parents/guardians of
the children.
Var Expression Analysis
RNA was obtained from TRIzolTM reagent (Invitrogen, catalog
number 15596026) preserved P. falciparum positive venous blood
samples, obtained from the children recruited for the study.
RNA was extracted using a Chloroform method (19) and cDNA
was synthesized using the Superscript III kit (Invitrogen, catalog
number 18091050) following the manufacturer’s protocol. Var
gene expression analysis was carried out through (a) PCR
amplification of a conserved region of the var genes (expressed
sequence tags) and sequencing using capillary and 454 platforms,
and (b) quantitative real-time PCR as described below.
a) Expressed sequence Tag (EST) sequencing
Using degenerate AF and BR primers (22), EST consisting
of the conserved DBLα region of the var genes were amplified
from the cDNA of each isolate by PCR. The PCR product was
cleaned and sequenced as described below.
i. 454 sequencing and sequence assembly
To enable sequencing, a multiple identifier (MID) tag
was ligated onto PCR products from each isolate. A total
of 48 MID tags were available allowing for pooling of 48
different isolates before sequencing using the 454 GS-FLX
3 Titanium technology using the standard protocol (Roche).
For each pool, sequencing success was determined using the
amount of data and length distribution of reads at the end
of the sequencing run. Pools that did not meet these criteria
were resequenced.
Reads from the data were partitioned using their MID
and pool identity. Reads shorter than 300 bp were excluded
from further analysis. The following methods were used
independently for each set of reads. The reads were assembled
with cap3 (version date 12/21/07) using the default settings
(23). The resulting contigs were clustered by putting contigs
with BLAST (version 2.2.25) matches of at least 98% identity
and 95% match length of the longest sequence into the same
cluster. Each cluster of contigs was assembled using cap3 with
the default settings (23). A ruby program bio-dbl-classifier was
used for classification of each of the assembled contigs into
their respective DBLα subgroup as described in Bull et al. (24).
Concurrently, the level of expression of each assembled contig
was determined by mapping all the reads from that isolate
to the assembled consensus contig sequences from the same
isolate at a 95% identity. The number of reads per contig,
DBLα classification file and the total number of reads for
each isolate were then used to determine the proportion of
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expression of each of the different DBLα subgroups in each
isolate using STATA as follows e.g., for each isolate,
% expression of Group A− like
=
no of contigs classified as group A − like
total no of reads
× 100 (1)
ii. EST sequencing by capillary
For 237 samples, the capillary sequencing platform was
used to sequence the amplified EST as described (18, 24). The
var expression data published in these studies are included in
this study.
b) Var transcript quantification using RT-PCR
Real-time PCR data was obtained as described (17, 25, 26).
Four primers targeting DC8 (named dc8-1, dc8-2, dc8-3,
dc8-4), one primer targeting DC13 (dc13) and two primers
targeting the majority of group A var genes (gpA1 and gpA2)
were used in real-time PCR analysis (Table S1). We also used
two primers, b1 and c2, targeting group B and C var genes,
respectively (27) (Table S1). Two housekeeping genes, Seryl
tRNA synthetase and Fructose bisphosphate aldolase (20, 28,
29) were used for relative quantification of the expressed
var genes. The PCR reaction and cycling conditions were
carried out as described in Lavstsen et al. (20) with the
Applied Biosystems 7500 Real-time PCR system. We set the
cycle threshold (Ct) at 0.025. Controls with no template were
included at the end of each batch of 22 samples per primer
and the melt-curves analyzed for non-specific amplification.
Genomic DNA from the IT4 laboratory parasite line at 10
ng/µl was used as a standard sample in all plates. The var
gene “transcript quantity” was determined relative to the
mean transcript of the two housekeeping genes, Seryl tRNA
synthetase and Fructose biphosphate aldolase as described
(20). For each test primer, the 1ct for both the test samples
and the standard genomic DNA was calculated and used
to generate the 11ct value which was then transformed
to arbitrary transcript unit (Tus) using the formula [Tus
= 2(5−11ct)]. However, we also estimated “proportional
expression” of the transcripts within each sample. When
calculating proportional expression from qPCR (described
under “statistical analysis” below), Tus calculated as described
in Lavstsen et al. (20) i.e., 2(5−1ct) were used. We assigned
a zero Tus value if a reaction did not result in detectable
amplification after 40 cycles of amplification, i.e., if the Ct
value was undetermined.
Flow Cytometry
We had a measure of antibodies to infected erythrocytes (αIE)
for 215 children from a previously published work (18), of which
27 were aged between 0 and 12 months and the rest were
older than 12 months. To boost the αIE data for the children
aged between 0 and 12 months, we measured αIE levels for 69
children who had available archived acute plasma samples. The
antibody level that each child had at the time of parasite sampling
was determined using Flow cytometry against one P. falciparum
clinical isolate matured ex vivo to the trophozoite stage and
cryopreserved in liquid nitrogen as described in Warimwe
et al. (18). The cryopreserved trophozoites were thawed as
previously described (30), erythrocyte pellet volume estimated,
parasitemia determined by microscopy and diluted to 1% using
fresh uninfected erythrocytes. The cells were resuspended in 0.5%
bovine serum albumin in 1% phosphate buffered saline (0.5%
BSA/PBS) such that 11.5 µl of the mixture contained 0.5 µl
of the cells. The reaction mixture was stained with Ethidium
bromide at a final concentration of 10µg/ml and 11.5 µl of
the mixture per well was aliquoted into U-bottom 96-well plates
(Falcon R©, catalog number BD 353077). One microliter of each
child’s acute plasma was pipetted into separate wells and the
mixture incubated for 30min at room temperature. Following
three washes with 0.5% BSA/PBS, the cells were incubated in
the dark for 30min at room temperature with 50 µl/well of
fluorescein isothiocynate (FITC)-conjugated sheep anti-human
IgG (Binding Site, catalog number AF004.X) diluted 1:50 in 0.5%
BSA/PBS. Following three washes, the cells were diluted 10-
fold in 0.5% BSA/PBS and at least 1000 IE acquired on a BD
FACs Canto II cytometer (BD Biosciences). Plasma from four
non-exposed European donors and one from a semi-immune
Kilifi adult were included in each plate and used as negative and
positive controls, respectively.
Data analysis was done using FlowJo v10 software
(TreeStar Inc.). Following initial gating to remove singlets,
IE were distinguished from uninfected erythrocytes on the
basis of their Ethidum Bromide staining. Next, median
fluorescence intensity on the FITC channel from each isolate
was obtained by subtracting the signal of the uninfected
from the infected erythrocytes signal (Figure S1). To cater
for non-specific binding, the mean median fluorescent
intensity of the four non-exposed sera on each plate was
subtracted from the median florescence intensities of each
child’s sample.
Statistical Analysis
The median transcript units from quantitative real time PCR
were calculated as follows; DC8 median from four primers used
(dc8-1, dc8-2, dc8-3 and dc8-4) and group A median from two
primers (gpA1 and gpA2). The proportion of transcripts for each
var group was then calculated from the sum of transcript (sum of
DC8 median, Group A median, DC13, B1, and C2) e.g.,
DC8 proportion =
DC8median
sum of transcript
(2)
Spearman’s rank correlation was used to determine the strength
of the correlations between different variables (e.g., var gene
expression with host age and host αIE). Scatter plots were used to
visualize the direction of correlations between var expression and
various variables including host age and αIE levels. All analysis
was done using Stata V13.
RESULTS
We used an expressed sequence tag approach (EST) to broadly
look at the proportional expression of different subsets of var
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genes. In addition, we used a real time PCR approach using
primers designed to detect various subsets of var genes. The
number of isolates whose var expression was analyzed using the
two approaches and more information about the primers used is
summarized in Table S1.
Parasite Group A Var Gene Expression
Increases With Age in the First Year of Life
We and others have previously reported negative correlations
between age and the expression of group A-like var genes
measured using the EST approach (15, 18, 19, 31). A similar
observation was made when expression of group A and DC8
was quantified by qPCR (17). In this study, we looked at the
correlation between age and var gene expression in the first
year of life and thereafter. We found that the expression of
cys2 and group A-like var genes, as determined from EST, was
positively correlated with host age in the first 12 months (cys2; p
= 0.005, group A-like; p = 0.0004, Figure 1A, Figures S2A,B).
Similarly, positive correlations were found with the transcript
quantity of group A var genes determined with both gpA1
and gpA2 primers (Table S1) designed to target broad group
A var genes (gpA1; p = 0.00007, gpA2; p = 0.003, Figure 1B,
Figures S2C,D). The relationships between the expression of
group A var genes and host age remained significant after
Bonferroni correction for 10 multiple comparisons (p = 0.0007,
and p = 0.03 for gpA1, and gpA2, respectively). In the first
year of life, expression of DC13 was positively associated
with host age (p < 0.005, Figure 1B, Figure S2E) though not
significant after correction for 10 multiple comparison (p =
0.05). The expression of group B var genes as determined with
b1 (Figure 1B, Figure S2J) and DC8 primers did not show
significant association with host age in the first year of life
(Figure 1B, Figures S2F,G). Unexpectedly, expression of group
C var genes (c2) showed positive associations with host age (p <
0.02, Figure 1B, Figure S2K).
We hypothesized that the positive correlation between the
expression of group A var genes and host age in the first
year of life was due to the decay of maternal antibodies.
If this were the case, an opposite effect would be expected
in children above 12 months as they become exposed to
malaria and make antibodies. In support of this, the transcript
quantity of group A var genes (except DC13) in children
over 12 months was negatively associated with host age
(group A-like; p = 0.004, gpA1; p = 0.0016, gpA2; p
= 0.0004, Figures 1A,B, Figures S2A–D). The relationship
between host age and the transcript quantity of DC8 var
genes, as expected, was in the negative direction (Figure 1B,
Figures S2F–I).
In an alternative approach, the proportion of group A,
B, C, and DC8 var gene transcript was calculated from the
estimated overall transcript quantity of group A, DC13, DC8,
group B, and C (17). In this analysis, only a subset of 654
observations that had expression data for all the var subsets
measured and age were included (Table S1). The proportion
of group B var genes (b1_prop) was negatively associated
with host age in the first year of life (p = 0.01, Figure 1B),
and positively associated with host age in children older
than 12 months (p = 0.002, Figure 1B). In contrast, the
proportional expression of group A var genes (gpA_prop)
was positively associated with host age in the first year of
life (p = 0.004, Figure 1B) and negatively associated with
host age in children older than 12 months (p = 0.00004,
Figure 1B). DC8 proportional expression association with host
age in the first year of life was not significant (Figure 1B)
but showed weak significant association after 12 months of
life (Figure 1B).
Group C proportional expression was not associated with age
in the first 12 months but was positively associated with age after
12 months (p= 0.0001, Figure 1B).
Antibodies to Infected Erythrocyte Surface
Antigens (αIE) Showed Negative and
Positive Associations With Host Age in
Children Up to 6 Months and Above 12
Months, Respectively
In malaria endemic regions, it is expected that there is a
positive correlation between host age and antibody levels
(18). For this study, due to the relatively rapid decay
in maternal antibodies during the first 6 months of life
and slow simultaneous acquisition of antibodies following
exposure to malaria, we hypothesized that overall there will
be a decline in host antibodies with age in the first year,
particularly in the first 6 months. Consistent with waning
maternal antibodies, the αIE levels was negatively correlated
with host age, especially in the first 6 months (p = 0.008,
Figure 1C). In contrast, positive correlation between host age
and αIE in children older than 12 months was observed (p <
0.00001, Figure 1C).
αIE Were Negatively Associated With
Expression of Group A and DC8 Var Gene
Subsets
As expected, we found significant negative correlations between
group A expression (both transcript quantity and proportional
expression) and αIE in both 0–12 months and above 12
months old children (Figures 1A,B). Similar correlation was also
observed between DC8 expression and αIE (Figure 1B). The
correlation between group B (b1) transcript quantity and αIE
was in the negative direction but significant only in the children
older than 12 months (Figure 1B) while group C (c2) transcript
quantity showed no association with αIE (Figure 1B). The
proportional expression of group B (b1_prop) and C (c2_prop)
were also not significantly correlated with αIE in the children
0–12 months old, however, group C proportional expression
showed significant positive correlation with αIE (Figure 1B).
This is in contrast to group A(gpA_prop) and DC8 (dc8_prop)
proportional expression which were in the negative direction
(Figure 1B). The correlation between var gene expression and
αIE in children aged 0–6 months was consistent with that of 0–
12 months, although the association was not reaching statistical
significance, most likely due to small sample size (Figures 1A,B).
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FIGURE 1 | Correlations between host age in months, host antibodies to infected erythrocytes (αIE) and var gene expression of the infecting parasites. Shown are
Spearman’s rank correlation coefficient (rho) for the associations between host age, host antibodies to IE (αIE), and expression of var genes of the infecting parasites
in children aged 0–6, 0–12, and above 12 months. Red background shading indicate positive correlation while blue shading indicate a negative correlation. Increasing
color intensity indicates increasing statistical significance of the correlation as indicated in the key [p < 0.00005 (darkest), p < 0.05 (lightest)]. (A) Associations of age
of the children and their αIE levels with expression of cys2 and group A-like var genes, (B) associations of age of the children and their αIE levels with var transcript
quantity obtained with primers targeting (i) group A var genes (gpA1, gpA2, dc13) and their proportion relative to the sum of the var transcript measured (gpA_prop),
(ii)DC8 var genes (dc8-1, dc8-2, dc8-3, and dc8-4) and their proportional expression (dc8_prop), (iii) group B var genes (b1) and their proportional expression
(b1_prop), and (iv) group C var genes (c2) and their proportional expression (c2_prop), (C) associations of age of the children and their αIE levels with var gene
expression homogeneity (VEH). Also shown is the associations of parasitemia with age and αIE levels of the children and the relationship between αIE and age of the
children. More details about the primers can be found in Table S1.
Var Expression Homogeneity (VEH) Was
Negatively Associated With Host Age and
Positively With Host Immunity (αIE) in the
First Year of Life
Previously, we observed the homogeneity of var expression
to increase with increasing host immunity. That is, the var
gene expression in parasites from naïve children was more
heterogeneous compared to semi-immune children such as
asymptomatics (32). In this study, we observed, in the first
year of life, VEH decreased with declining αIE and increasing
age as demonstrated by the positive and negative association
with host αIE and age, respectively (αIE; p = 0.03, age; p =
0.001, Figure 1C).
Parasitemia Increased With Declining αIE
and Increasing Host Age in the First Year of
Life
We finally examined the potential role of αIE in controlling
parasitemia in the first year of life and after (Figure 1C). As
shown in Figure 1C, parasitemia showed positive association
with host age in the first 6 months of life (p = 0.03, Figure 1C).
During this period, parasitemia also increased with declining
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αIE as shown by the negative correlation with αIE (p = 0.03,
Figure 1C). In contrast, parasitemia decreased with increasing
host age and αIE after 12 months of life (age; p = 0.002, αIE;
p< 0.0001, Figure 1C) when the children are expected to acquire
αIE with time as a result of continuous exposure to malaria.
This result reinforces a role for maternal αIE in limiting in vivo
parasite expansion and severe malaria during infancy.
DISCUSSION
This study set out to investigate the relationship between the
expression of var genes that have been associated with severe
malaria and host age in children between 0 and 12 months, the
age during which maternal immunity declines. We hypothesized
that there will be a positive correlation between the expression
of group A var genes and host age in children 0–12 months old
after which the relationship will change to a negative correlation.
As expected, DC8, DC13 and group A var genes showed positive
associations with host age in children 0–12 months old.
The simplest explanation for these changes in var expression
patterns is that they reflect the decay of maternal antibodies
with increasing age in children between 0 and 12 months old,
leading to increased survival of parasites expressing group A
var genes. This allows parasites expressing group A var genes
to dominate the infection. Subsequent acquisition of antibodies
against these var genes results as children gain exposure to
infection, consequently leading to a decline in group A-like var
gene expression levels in older children (>12months). Our result
is consistent with the above explanation as αIE levels declined in
the first 6 months of age, a period of rapid decline of maternal
antibodies as observed in other studies (4, 5).
As expected the αIE showed negative association with both
host age and var expression in the children between 0 and 12
months old and the subset<6 months of age. This contrasts with
the positive relationship between host age and αIE in children
older than 12 months (Figure 1). One caveat of the αIE data for
the children 0–12 months is that the αIE levels were measured
against one clinical isolate but in a previous study in which
antibodies were tested against 8 different isolates, antibodies to
each one of these correlated negatively with the expression of
group A-like var genes suggesting that a single parasite isolate
can be used as a surrogate of host immunity (18).
The explanation that the observed positive relationship
between var gene expression and host age in the first year of life
is due to the waning maternal antibodies is further supported by
the var expression homogeneity data where significant negative
and positive correlation with host age and αIE, respectively, was
observed. That is, as the maternal antibody wanes, the var gene
expression homogeneity decreases which is consistent with a
previous study that demonstrated that homogeneity of var gene
expression is lowest in children with severe malaria and low αIE
as compared to children with asymptomatic infection and high
αIE (32).
The observed rise in parasitemia with declining αIE during
the first 6 months of life (Figure 1C) is also supportive of a role
for maternal αIE in controlling parasitemia potentially through
selection against parasites expressing group A and DC8 var
genes. These subsets of genes mediate stronger cytoadhesion of
IE and sequestration in the organs (13, 18, 20, 33), allowing
IE escape removal by the spleen and thus promoting in vivo
expansion of the parasite population. Maternal αIE targeting
group A and DC8 var genes are expected to limit parasite
expansion through inhibition of IE sequestration, rendering the
IE vulnerable to splenic clearance (26, 34–36).
Other factors have been proposed to protect against malaria
in infants and may play a role in modifying var expression
during infancy. Fetal hemoglobin (HbF) has been demonstrated
to decline in the first year of life (37). It is possible that the
decline of HbF in the first year of life could explain the increasing
expression of group A var genes over the same period and that
this coincidentally mimics the effect of antibodies on parasite
gene expression. Hemoglobinopathies such as sickle trait have
been proposed to protect against malaria by reducing the amount
of PfEMP1 trafficked to the surface of IE (38). There is also
evidence that sickle red cells can modify the parasite gene
expression at transcriptional level through red cell microRNA
that translocate into the parasite (39). This raises the possibility
that other abnormal hemoglobin, such as HbF, may as well
contribute to protection by reducing var gene expression and
cytoadhesion (40). HbF has been suggested to work together with
maternally acquired antibodies to protect infants from malaria
(41) perhaps by impairing cytoadhesion and promoting clearance
of IE. This suggestion is consistent with our result showing
that expression of group A var genes increases over the period
when both HbF and maternal antibodies are expected to wane.
Dissecting the relative contribution of HbF and maternal αIE
on the parasite var gene expression during the first year of life
warrants further investigation.
In conclusion, we have tested the prediction that, if maternal
antibodies play a role in protecting infants against severe malaria,
they would impose a selection pressure on the infecting parasite
population that is similar to that previously described in children
as they gain exposure to P. falciparum infection. The results
show that parasites infecting infants, show var gene expression
patterns that are highly similar to those previously described for
parasites under immune selection. Future studies that relate αIE
levels in cord blood with var gene expression patterns during
first infection, or longitudinal studies of mother-infant pairs,
would be required to provide a definitive link between maternal
antibodies and protection against severe malaria in the first
months of life.
DATA AVAILABILITY STATEMENT
The datasets generated for this study can be found in the Harvard
Dataverse, URL: https://doi.org/10.7910/DVN/VGRAVH.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by KEMRI/SERU/3149 Kenya Medical Research
Institute. Written informed consent to participate in this study
was provided by the participants’ legal parents/guardians.
Frontiers in Immunology | www.frontiersin.org 6 October 2019 | Volume 10 | Article 2328
Kivisi et al. Var Expression During Infant Malaria
AUTHOR CONTRIBUTIONS
PB, KM, CK, and AA contributed to the design and
implementation of the research. CK, AA, and MM performed
the experiments with contributions from MH, GF, TO, GG,
GW, and RR for sequence data and statistical analyses. The
manuscript was prepared by CK with contributions from
AA, KM, GF, and PB. All authors read and approved the
final manuscript.
FUNDING
This work was supported by Wellcome Trust grants; 084535 to
PB, 084538 to KM, 209289 to AA, and 080883 to CK.
ACKNOWLEDGMENTS
We would like to acknowledge the parents and guardians of the
children who participated in this study. We would like to thank
Dr. Matthew Berriman of the Wellcome Sanger Institute whose
team supported this work and Prof. Chris Newbold ofWeatherall
Institute, University of Oxford for useful discussions. This paper
is published with the permission of the office of KEMRI Director.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2019.02328/full#supplementary-material
REFERENCES
1. Macdonald G. The analysis of malaria parasite rates in infants. Trop Dis Bull.
(1950) 47:915–38.
2. Snow RW, Marsh K. The epidemiology of clinical malaria
among African children. Bull Inst Pasteur. (1998) 96:15–
23. doi: 10.1016/S0020-2452(98)80025-0
3. Ceesay SJ, Koivogui L, Nahum A, Taal MA, Okebe J, Affara M, et al. Malaria
prevalence among young infants in different transmission settings, Africa.
Emerg Infect Dis. (2015) 21:1114–21. doi: 10.3201/eid2107.142036
4. Riley EM, Wagner GE, Ofori MF, Wheeler JG, Akanmori BD, Tetteh K,
et al. Lack of association between maternal antibody and protection of
African infants from malaria infection. Infect Immun. (2000) 68:5856–
63. doi: 10.1128/IAI.68.10.5856-5863.2000
5. Murungi LM, Sonden K, Odera D, Oduor LB, Guleid F, Nkumama
IN, et al. Cord blood IgG and the risk of severe Plasmodium
falciparum malaria in the first year of life. Int J Parasitol. (2016)
47:153–62. doi: 10.1016/j.ijpara.2016.09.005
6. Deloron P, Dubois B, Le Hesran JY, Riche D, Fievet N, Cornet M, et al. Isotypic
analysis of maternally transmitted Plasmodium falciparum-specific antibodies
in Cameroon, and relationship with risk of P. falciparum infection. Clin Exp
Immunol. (1997) 110:212–8. doi: 10.1111/j.1365-2249.1997.tb08319.x
7. Hogh B, Marbiah NT, Burghaus PA, Andersen PK. Relationship between
maternally derived anti-Plasmodium falciparum antibodies and risk of
infection and disease in infants living in an area of Liberia, west Africa, in
which malaria is highly endemic. Infect Immun. (1995) 63:4034–8.
8. Dobbs KR, Dent AE. Plasmodium malaria and antimalarial
antibodies in the first year of life. Parasitology. (2016) 143:129–
38. doi: 10.1017/S0031182015001626
9. Lavstsen T, Salanti A, Jensen AT, Arnot DE, Theander TG. Sub-grouping of
Plasmodium falciparum 3D7 var genes based on sequence analysis of coding
and non-coding regions.Malar J. (2003) 2:27. doi: 10.1186/1475-2875-2-27
10. Bull PC, Abdi AI. The role of PfEMP1 as targets of naturally acquired
immunity to childhood malaria: prospects for a vaccine. Parasitology. (2016)
143:171–86. doi: 10.1017/S0031182015001274
11. Pongponratn E, Riganti M, Punpoowong B, Aikawa M. Microvascular
sequestration of parasitized erythrocytes in human falciparum
malaria: a pathological study. Am J Trop Med Hyg. (1991)
44:168–75. doi: 10.4269/ajtmh.1991.44.168
12. Avril M, Tripathi AK, Brazier AJ, Andisi C, Janes JH, Soma VL, et al. A
restricted subset of var genes mediates adherence of Plasmodium falciparum-
infected erythrocytes to brain endothelial cells. Proc Natl Acad Sci USA. (2012)
109:E1782–90. doi: 10.1073/pnas.1120534109
13. Claessens A, Adams Y, Ghumra A, Lindergard G, Buchan CC, Andisi C, et al.
A subset of group A-like var genes encodes the malaria parasite ligands for
binding to human brain endothelial cells. Proc Natl Acad Sci USA. (2012)
109:E1772–81. doi: 10.1073/pnas.1120461109
14. Smith JD, Craig AG, Kriek N, Hudson-Taylor D, Kyes S, Fagan T,
et al. Identification of a Plasmodium falciparum intercellular adhesion
molecule-1 binding domain: a parasite adhesion trait implicated in cerebral
malaria. Proc Natl Acad Sci USA. (2000) 97:1766–71. doi: 10.1073/pnas.04
0545897
15. Warimwe GM, Fegan G, Musyoki JN, Newton CR, Opiyo M, Githinji
G, et al. Prognostic indicators of life-threatening malaria are associated
with distinct parasite variant antigen profiles. Sci Transl Med. (2012)
4:129ra45. doi: 10.1126/scitranslmed.3003247
16. Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is
associated with malaria severity in Kenya. Infect Immun. (1995) 63:2323–6.
17. Abdi AI, Warimwe GM, Muthui MK, Kivisi CA, Kiragu EW, Fegan GW, et al.
Global selection of Plasmodium falciparum virulence antigen expression by
host antibodies. Sci Rep. (2016) 6:19882. doi: 10.1038/srep19882
18. Warimwe GM, Keane TM, Fegan G, Musyoki JN, Newton CR, Pain A,
et al. Plasmodium falciparum var gene expression is modified by host
immunity. Proc Natl Acad Sci USA. (2009) 106:21801–6. doi: 10.1073/pnas.090
7590106
19. Bull PC, Berriman M, Kyes S, Quail MA, Hall N, Kortok MM,
et al. Plasmodium falciparum variant surface antigen expression patterns
during malaria. PLoS Pathog. (2005) 1:e26. doi: 10.1371/journal.ppat.
0010026
20. Lavstsen T, Turner L, Saguti F, Magistrado P, Rask TS, Jespersen JS, et al.
Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8
and 13 are associated with severe malaria in children. Proc Natl Acad Sci USA.
(2012) 109:E1791–800. doi: 10.1073/pnas.1120455109
21. Mwaniki MK, Talbert AW, Mturi FN, Berkley JA, Kager P, Marsh K, et al.
Congenital and neonatal malaria in a rural Kenyan district hospital: an
eight-year analysis.Malar J. (2010) 9:313. doi: 10.1186/1475-2875-9-313
22. Taylor HM, Kyes SA, Harris D, Kriek N, Newbold CI. A study of var gene
transcription in vitro using universal var gene primers.Mol Biochem Parasitol.
(2000) 105:13–23. doi: 10.1016/S0166-6851(99)00159-0
23. Huang X, Madan A. CAP3: A DNA sequence assembly program. Genome Res.
(1999) 9:868–77. doi: 10.1101/gr.9.9.868
24. Bull PC, Kyes S, Buckee CO, Montgomery J, Kortok MM, Newbold
CI, et al. An approach to classifying sequence tags sampled from
Plasmodium falciparum var genes. Mol Biochem Parasitol. (2007) 154:98–
102. doi: 10.1016/j.molbiopara.2007.03.011
25. Abdi AI, Kariuki SM, Muthui MK, Kivisi CA, Fegan G, Gitau
E, et al. Differential Plasmodium falciparum surface antigen
expression among children with Malarial Retinopathy. Sci Rep. (2015)
5:18034. doi: 10.1038/srep18034
26. Abdi AI, Hodgson SH, Muthui MK, Kivisi CA, Kamuyu G, Kimani D, et al.
Plasmodium falciparum malaria parasite var gene expression is modified
by host antibodies: longitudinal evidence from controlled infections of
Kenyan adults with varying natural exposure. BMC Infect Dis. (2017)
17:585. doi: 10.1186/s12879-017-2686-0
27. Rottmann M, Lavstsen T, Mugasa JP, Kaestli M, Jensen AT, Muller D, et al.
Differential expression of var gene groups is associated with morbidity caused
by Plasmodium falciparum infection in Tanzanian children. Infect Immun.
(2006) 74:3904–11. doi: 10.1128/IAI.02073-05
Frontiers in Immunology | www.frontiersin.org 7 October 2019 | Volume 10 | Article 2328
Kivisi et al. Var Expression During Infant Malaria
28. Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, et al.
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.
J Exp Med. (2004) 200:1197–203. doi: 10.1084/jem.20041579
29. Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE,
et al. Selective upregulation of a single distinctly structured var
gene in chondroitin sulphate A-adhering Plasmodium falciparum
involved in pregnancy-associated malaria. Mol Microbiol. (2003)
49:179–91. doi: 10.1046/j.1365-2958.2003.03570.x
30. Kinyanjui SM, Howard T, Williams TN, Bull PC, Newbold CI, Marsh
K. The use of cryopreserved mature trophozoites in assessing antibody
recognition of variant surface antigens of Plasmodium falciparum-infected
erythrocytes. J Immunol Methods. (2004) 288:9–18. doi: 10.1016/j.jim.2004.
01.022
31. Normark J, Nilsson D, Ribacke U, Winter G, Moll K, Wheelock CE,
et al. PfEMP1-DBL1alpha amino acid motifs in severe disease states of
Plasmodium falciparum malaria. Proc Natl Acad Sci USA. (2007) 104:15835–
40. doi: 10.1073/pnas.0610485104
32. Warimwe GM, Recker M, Kiragu EW, Buckee CO, Wambua J, Musyoki
JN, et al. Plasmodium falciparum var gene expression homogeneity
as a marker of the host-parasite relationship under different levels
of naturally acquired immunity to malaria. PLoS ONE. (2013)
8:e70467. doi: 10.1371/journal.pone.0070467
33. Jensen AT, Magistrado P, Sharp S, Joergensen L, Lavstsen T, Chiucchiuini
A, et al. Plasmodium falciparum associated with severe childhood malaria
preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med.
(2004) 199:1179–90. doi: 10.1084/jem.20040274
34. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite
antigens on the infected red cell surface are targets for naturally acquired
immunity to malaria. Nat Med. (1998) 4:358–60. doi: 10.1038/nm0398-358
35. Chen Q, Pettersson F, Vogt AM, Schmidt B, Ahuja S, Liljestrom P,
et al. Immunization with PfEMP1-DBL1alpha generates antibodies
that disrupt rosettes and protect against the sequestration of
Plasmodium falciparum-infected erythrocytes. Vaccine. (2004) 22:2701–12.
doi: 10.1016/j.vaccine.2004.02.015
36. Ghumra A, Semblat JP, Ataide R, Kifude C, Adams Y, Claessens A,
et al. Induction of strain-transcending antibodies against Group A PfEMP1
surface antigens from virulent malaria parasites. PLoS Pathog. (2012)
8:e1002665. doi: 10.1371/journal.ppat.1002665
37. Colombo B, Kim B, Atencio RP, Molina C, Terrenato L. The pattern of
fetal haemoglobin disappearance after birth. Br J Haematol. (1976) 32:79–
87. doi: 10.1111/j.1365-2141.1976.tb01877.x
38. Cyrklaff M, Sanchez CP, Kilian N, Bisseye C, Simpore J, Frischknecht
F, et al. Hemoglobins S and C interfere with actin remodeling in
Plasmodium falciparum-infected erythrocytes. Science. (2011) 334:1283–
6. doi: 10.1126/science.1213775
39. LaMonte G, Philip N, Reardon J, Lacsina JR, Majoros W, Chapman L,
et al. Translocation of sickle cell erythrocyte microRNAs into Plasmodium
falciparum inhibits parasite translation and contributes to malaria resistance.
Cell Host Microbe. (2012) 12:187–99. doi: 10.1016/j.chom.2012.06.007
40. Archer NM, Petersen N, Duraisingh MT. Fetal hemoglobin does
not inhibit Plasmodium falciparum growth. Blood Adv. (2019)
3:2149–52. doi: 10.1182/bloodadvances.2019000399
41. Amaratunga C, Lopera-Mesa TM, Brittain NJ, Cholera R, Arie T, Fujioka
H, et al. A role for fetal hemoglobin and maternal immune IgG in
infant resistance to Plasmodium falciparum malaria. PLoS ONE. (2011)
6:e14798. doi: 10.1371/journal.pone.0014798
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2019 Kivisi, Muthui, Hunt, Fegan, Otto, Githinji, Warimwe, Rance,
Marsh, Bull and Abdi. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Immunology | www.frontiersin.org 8 October 2019 | Volume 10 | Article 2328
